Medicap Healthcare cuts IPO size 29% to USD 18.3m, drops pre-IPO placement
Indian pharmaceutical closures maker Medicap Healthcare has cut its planned IPO to USD 18.3m (INR 1.7bn) from USD 25.9m (INR 2.4bn) and dropped a pre-IPO placement, under a board resolution of 15 November 2026. The Gujarat-based company, which makes Euro Head caps and bottle preforms at its Vadodara plant, filed its draft prospectus in September 2025 and received SEBI approval in January 2026.
Why this mattersThe smaller offer still funds USD 9.0m (INR 830m) of machinery for 966m units a year of added closure and preform capacity in Indian pharmaceutical packaging.
- IPO size cut 29% to USD 18.3m (INR 1.7bn) from USD 25.9m (INR 2.4bn)
- Pre-IPO placement component dropped from the offer structure
- Board resolution approving the revision dated 15 November 2026; addendum published 21 November 2026
- USD 9.0m (INR 830m) of net proceeds earmarked for plant and machinery at the Vadodara facility
- USD 4.7m (INR 440m) of net proceeds allocated to debt repayment
- Planned expansion adds 966m units a year of capacity: 696m caps and closures and 270m bottle preforms
Sources
moneycontrol.com